Acute Myeloid Leukemia Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: A9D30D3D214FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Acute Myeloid Leukemia in Global, including the following market information:

Global Acute Myeloid Leukemia Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Acute Myeloid Leukemia market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Myeloid Leukemia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Myeloid Leukemia Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Acute Myeloid Leukemia Market Segment Percentages, By Type, 2020 (%)

• Chemotherapy
• Targeted Therapy

China Acute Myeloid Leukemia Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Acute Myeloid Leukemia Market Segment Percentages, By Application, 2020 (%)

• Adults
• Children

Global Acute Myeloid Leukemia Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Acute Myeloid Leukemia Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Acute Myeloid Leukemia Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Acute Myeloid Leukemia Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• GSK
• Novartis
• Roche
• Bristol-Myers Squibb
• Celgene
• Clavis Pharma ASA
• Daiichi Sankyo
• Eisai
• Teva
• Sunesis Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acute Myeloid Leukemia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACUTE MYELOID LEUKEMIA OVERALL MARKET SIZE

2.1 Global Acute Myeloid Leukemia Market Size: 2021 VS 2027
2.2 Global Acute Myeloid Leukemia Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acute Myeloid Leukemia Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acute Myeloid Leukemia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Players in Global Market
  3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Acute Myeloid Leukemia Market Size Markets, 2021 & 2027
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapy
4.2 By Type - Global Acute Myeloid Leukemia Revenue & Forecasts
  4.2.1 By Type - Global Acute Myeloid Leukemia Revenue, 2016-2021
  4.2.2 By Type - Global Acute Myeloid Leukemia Revenue, 2022-2027
  4.2.3 By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acute Myeloid Leukemia Market Size, 2021 & 2027
  5.1.2 Adults
  5.1.3 Children
5.2 By Application - Global Acute Myeloid Leukemia Revenue & Forecasts
  5.2.1 By Application - Global Acute Myeloid Leukemia Revenue, 2016-2021
  5.2.2 By Application - Global Acute Myeloid Leukemia Revenue, 2022-2027
  5.2.3 By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Acute Myeloid Leukemia Market Size, 2021 & 2027
6.2 By Region - Global Acute Myeloid Leukemia Revenue & Forecasts
  6.2.1 By Region - Global Acute Myeloid Leukemia Revenue, 2016-2021
  6.2.2 By Region - Global Acute Myeloid Leukemia Revenue, 2022-2027
  6.2.3 By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Acute Myeloid Leukemia Revenue, 2016-2027
  6.3.2 US Acute Myeloid Leukemia Market Size, 2016-2027
  6.3.3 Canada Acute Myeloid Leukemia Market Size, 2016-2027
  6.3.4 Mexico Acute Myeloid Leukemia Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Acute Myeloid Leukemia Revenue, 2016-2027
  6.4.2 Germany Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.3 France Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.4 U.K. Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.5 Italy Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.6 Russia Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.7 Nordic Countries Acute Myeloid Leukemia Market Size, 2016-2027
  6.4.8 Benelux Acute Myeloid Leukemia Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Acute Myeloid Leukemia Revenue, 2016-2027
  6.5.2 China Acute Myeloid Leukemia Market Size, 2016-2027
  6.5.3 Japan Acute Myeloid Leukemia Market Size, 2016-2027
  6.5.4 South Korea Acute Myeloid Leukemia Market Size, 2016-2027
  6.5.5 Southeast Asia Acute Myeloid Leukemia Market Size, 2016-2027
  6.5.6 India Acute Myeloid Leukemia Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Acute Myeloid Leukemia Revenue, 2016-2027
  6.6.2 Brazil Acute Myeloid Leukemia Market Size, 2016-2027
  6.6.3 Argentina Acute Myeloid Leukemia Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, 2016-2027
  6.7.2 Turkey Acute Myeloid Leukemia Market Size, 2016-2027
  6.7.3 Israel Acute Myeloid Leukemia Market Size, 2016-2027
  6.7.4 Saudi Arabia Acute Myeloid Leukemia Market Size, 2016-2027
  6.7.5 UAE Acute Myeloid Leukemia Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Acute Myeloid Leukemia Major Product Offerings
  7.1.4 GSK Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.1.5 GSK Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Acute Myeloid Leukemia Major Product Offerings
  7.2.4 Novartis Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.2.5 Novartis Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Acute Myeloid Leukemia Major Product Offerings
  7.3.4 Roche Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.3.5 Roche Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia Major Product Offerings
  7.4.4 Bristol-Myers Squibb Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Celgene
  7.5.1 Celgene Corporate Summary
  7.5.2 Celgene Business Overview
  7.5.3 Celgene Acute Myeloid Leukemia Major Product Offerings
  7.5.4 Celgene Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.5.5 Celgene Key News
7.6 Clavis Pharma ASA
  7.6.1 Clavis Pharma ASA Corporate Summary
  7.6.2 Clavis Pharma ASA Business Overview
  7.6.3 Clavis Pharma ASA Acute Myeloid Leukemia Major Product Offerings
  7.6.4 Clavis Pharma ASA Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.6.5 Clavis Pharma ASA Key News
7.7 Daiichi Sankyo
  7.7.1 Daiichi Sankyo Corporate Summary
  7.7.2 Daiichi Sankyo Business Overview
  7.7.3 Daiichi Sankyo Acute Myeloid Leukemia Major Product Offerings
  7.4.4 Daiichi Sankyo Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.7.5 Daiichi Sankyo Key News
7.8 Eisai
  7.8.1 Eisai Corporate Summary
  7.8.2 Eisai Business Overview
  7.8.3 Eisai Acute Myeloid Leukemia Major Product Offerings
  7.8.4 Eisai Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.8.5 Eisai Key News
7.9 Teva
  7.9.1 Teva Corporate Summary
  7.9.2 Teva Business Overview
  7.9.3 Teva Acute Myeloid Leukemia Major Product Offerings
  7.9.4 Teva Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.9.5 Teva Key News
7.10 Sunesis Pharmaceuticals
  7.10.1 Sunesis Pharmaceuticals Corporate Summary
  7.10.2 Sunesis Pharmaceuticals Business Overview
  7.10.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Major Product Offerings
  7.10.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue in Global (2016-2021)
  7.10.5 Sunesis Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute Myeloid Leukemia Market Opportunities & Trends in Global Market
Table 2. Acute Myeloid Leukemia Market Drivers in Global Market
Table 3. Acute Myeloid Leukemia Market Restraints in Global Market
Table 4. Key Players of Acute Myeloid Leukemia in Global Market
Table 5. Top Acute Myeloid Leukemia Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute Myeloid Leukemia Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute Myeloid Leukemia Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute Myeloid Leukemia Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2022-2027
Table 30. GSK Corporate Summary
Table 31. GSK Acute Myeloid Leukemia Product Offerings
Table 32. GSK Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Acute Myeloid Leukemia Product Offerings
Table 35. Novartis Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Acute Myeloid Leukemia Product Offerings
Table 38. Roche Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Acute Myeloid Leukemia Product Offerings
Table 41. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 42. Celgene Corporate Summary
Table 43. Celgene Acute Myeloid Leukemia Product Offerings
Table 44. Celgene Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 45. Clavis Pharma ASA Corporate Summary
Table 46. Clavis Pharma ASA Acute Myeloid Leukemia Product Offerings
Table 47. Clavis Pharma ASA Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 48. Daiichi Sankyo Corporate Summary
Table 49. Daiichi Sankyo Acute Myeloid Leukemia Product Offerings
Table 50. Daiichi Sankyo Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 51. Eisai Corporate Summary
Table 52. Eisai Acute Myeloid Leukemia Product Offerings
Table 53. Eisai Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 54. Teva Corporate Summary
Table 55. Teva Acute Myeloid Leukemia Product Offerings
Table 56. Teva Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)
Table 57. Sunesis Pharmaceuticals Corporate Summary
Table 58. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product Offerings
Table 59. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Acute Myeloid Leukemia Segment by Type
Figure 2. Acute Myeloid Leukemia Segment by Application
Figure 3. Global Acute Myeloid Leukemia Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2020
Figure 8. By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 9. By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 10. By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 11. By Country - North America Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 12. US Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 16. Germany Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 17. France Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 24. China Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 28. India Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 30. Brazil Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue Market Share, 2016-2027
Figure 33. Turkey Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Acute Myeloid Leukemia Revenue, (US$, Mn), 2016-2027
Figure 37. GSK Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Celgene Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Clavis Pharma ASA Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Daiichi Sankyo Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Eisai Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Teva Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)